ARL, GMC, ECR, UD, HF, KS, DC, AS, JP, and TJH state no conflicts of interest.

NF’s disclosures are as follows:

Advisory/consulting: Merck, Pfizer, Mirati, AstraZeneca, Regeneron, and NeoGenomics, Inc. Research funding: Genentech.

SY’s disclosures are as follows:

Advisory Board: Astrazeneca (Institutional- no personal compensation). Research funding: Astrazeneca, Repare Therapeutics (Institutional).